Bateman, Horie recognized for method to detect, stage Alzheimer’s disease
WashU Medicine researchers Randall J. Bateman, MD, and Kanta Horie, PhD, received the 2026 Jeffrey L. Morby Prize from Cure Alzheimer’s Fund for developing a blood test that detects and stages Alzheimer’s by measuring toxic proteins in the brain.
Wu named Pew Biomedical Scholar
WashU Medicine molecular microbiologist Meng Wu was honored for her research on how early-life gut microbes shape lifelong immunity.
Three new genetic modifiers connected to risk in Alzheimer’s disease
WashU Medicine researchers and collaborators discovered three new chromosomal locations that may be connected to earlier disease onset or faster disease progression in dominantly inherited Alzheimer’s disease, pointing to new directions for Alzheimer’s research.
WashU announces new academic-industry collaboration with Bristol Myers Squibb
WashU and Bristol Myers Squibb have formed a multiyear collaboration to advance drug development projects in the neurosciences. WashU medical and research trainees will have opportunities to work alongside the company’s scientists at its facilities as part of the agreement.
Tendon variations’ effects on mechanics to get a closer look
WashU researchers have received a federal grant to study the mechanobiological properties of tendons, work that could help to prevent common tendon injuries as well as inform new treatment strategies.
Benzinger, Schindler honored by international imaging society
Tammie L.S. Benzinger, MD, PhD, and Thomas H. Schindler, MD, PhD, both of WashU Medicine’s Mallinckrodt Institute of Radiology, have been recognized with prestigious awards from the Society for Nuclear Medicine & Molecular Imaging.
Mental health, environment shape pregnancy sleep
Using machine learning, researchers at WashU Bursky Public Health identified the factors most strongly linked to poor sleep during late pregnancy.
New tool to help research fibrosis, cancer
Biomedical engineers at WashU have created a new platform to study mechanobiology, which can help with research on cancer and fibrosis.
Cao named Guggenheim Fellow
Yin Cao, ScD, an associate professor in the Division of Public Health Sciences in the WashU Medicine Mary Culver Department of Surgery, has been named a 2026 Fellow of the 101st class of the John Simon Guggenheim Memorial Foundation.
Tool to predict brain swelling earns FDA Breakthrough Device designation
An AI-enabled software tool developed by WashU Medicine researchers is the first device to predict malignant cerebral edema, a dangerous complication of acute stroke.
Older Stories